Receive our newsletter – data, insights and analysis delivered to you
September 25, 2011

Gynesonics commences study for the VizAblate system

Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine fibroids associated with heavy menstrual bleeding.

By admin-demo

Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine fibroids associated with heavy menstrual bleeding.

The CE-marked VizAblate system combines ultrasound image guidance with radiofrequency ablation to treat fibroids transcervically in an outpatient setting.

The VizAblate system is currently available for investigational use only in the US.

Related Companies

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU